Cannabis Market in Mississippi

Mississippi's path to medical cannabis legalization was unusually complex. Voters overwhelmingly approved Initiative 65 in November 2020, but the Mississippi Supreme Court struck down the initiative in May 2021 due to a technicality in the state's ballot initiative process. The legislature subsequently passed a medical cannabis bill — the Mississippi Medical Cannabis Act — which Governor Tate Reeves signed in February 2022.

The Mississippi medical cannabis market is still in its early stages, with dispensaries beginning to open in 2023. The program allows patients with qualifying conditions to purchase up to 3.5 grams of cannabis per day. The market is expected to remain modest given the state's population of approximately 3 million and the conservative political environment that limits the likelihood of near-term recreational expansion.

No major multi-state operators have entered the Mississippi market as of 2025. The state's relatively new program, small market size, and regulatory uncertainty have kept national operators on the sidelines. The market is currently served by local and regional operators. Mississippi's standard 7% state sales tax applies to medical cannabis sales, with no additional cannabis-specific excise tax.

The Mississippi cannabis market is regulated by the Mississippi State Department of Health, which oversees licensing, compliance, and enforcement for all cannabis businesses operating within the state. The regulatory body is responsible for issuing and renewing licenses, conducting inspections, enforcing packaging and labeling requirements, managing the seed-to-sale tracking system, and handling complaints and disciplinary actions.

The current tax structure for cannabis in Mississippi is: 7% state sales tax applies to medical cannabis. Tax policy plays a critical role in determining the competitiveness of the legal cannabis market relative to the illicit market. States with excessively high tax rates often see consumers shift to unlicensed sources, while states with moderate rates tend to achieve higher legal market capture. Operators in Mississippi must also comply with comprehensive regulatory requirements including testing, labeling, advertising restrictions, and security protocols.

Investors considering exposure to the Mississippi cannabis market should evaluate several factors. The state's medical legal status, estimated market size of $60M, and limited MSO presence all influence the investment landscape. Market maturity, competitive dynamics, and regulatory stability are important considerations when evaluating companies with Mississippi operations.

Cannabis stocks carry significant risks including federal illegality, regulatory uncertainty, limited access to banking services, and high tax burdens under IRC Section 280E. State-level factors such as license availability, tax rates, and enforcement against the illicit market can materially impact the profitability of licensed operators. Investors should consider a company's overall state portfolio diversification rather than relying on exposure to any single state market. Past performance does not guarantee future results, and cannabis investments may not be suitable for all investors.